Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.21% |
| 2 | Healthcare | 10.45% |
| 3 | Technology | 8.65% |
| 4 | Financials | 8.6% |
| 5 | Consumer Discretionary | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Invesco Senior Income Trust
VVR
$451M
| $3.43M | ﹤0.01% |
+800,096
| New | +$3.34M |
|
2202
Barings BDC
BBDC
$979M
| $3.43M | ﹤0.01% |
333,542
-116,168
| -26% | -$1.19M |
|
|
SPNS
2203
DELISTED
Sapiens International
SPNS
| $3.42M | ﹤0.01% |
148,751
-40,327
| -21% | -$872K |
|
|
ZUO
2204
DELISTED
Zuora, Inc.
ZUO
| $3.42M | ﹤0.01% |
238,418
+19,958
| +9% | +$292K |
|
2205
CALL
Biogen
BIIB
$32.3B
| $3.41M | ﹤0.01% |
11,500
-180,000
| -94% | -$49.9M |
|
|
FLIR
2206
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $3.4M | ﹤0.01% |
65,385
+58,760
| +887% | +$3.11M |
|
2207
Teradata
TDC
$2.68B
| $3.4M | ﹤0.01% |
127,158
-442,551
| -78% | -$12.3M |
|
2208
ProQR Therapeutics
PRQR
$323M
| $3.4M | ﹤0.01% |
343,146
+120,567
| +54% | +$939K |
|
|
DHR.PRA
2209
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $3.4M | ﹤0.01% |
2,878
-38
| -1% | -$42.8K |
|
2210
MasterCraft Boat Holdings
MCFT
$579M
| $3.4M | ﹤0.01% |
+215,590
| New | +$3.4M |
|
|
ENLC
2211
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $3.39M | ﹤0.01% |
552,742
+536,803
| +3,368% | +$3.26M |
|
|
KNL
2212
DELISTED
Knoll, Inc.
KNL
| $3.38M | ﹤0.01% |
+133,652
| New | +$3.53M |
|
2213
Fox Class B
FOX
$25.8B
| $3.37M | ﹤0.01% |
92,537
-528,928
| -85% | -$17.8M |
|
|
FARO
2214
DELISTED
Faro Technologies
FARO
| $3.36M | ﹤0.01% |
66,754
+50,146
| +302% | +$2.45M |
|
2215
Cabaletta Bio
CABA
$529M
| $3.35M | ﹤0.01% |
+239,950
| New | +$2.84M |
|
2216
WaFd
WAFD
$2.67B
| $3.35M | ﹤0.01% |
91,330
+41,947
| +85% | +$1.54M |
|
|
FINV
2217
FinVolution Group
FINV
$803M
| $3.34M | ﹤0.01% |
1,261,152
-175,891
| -12% | -$466K |
|
2218
Capital City Bank Group
CCBG
$879M
| $3.34M | ﹤0.01% |
109,437
+49,487
| +83% | +$1.43M |
|
|
NGD
2219
DELISTED
New Gold Inc
NGD
| $3.34M | ﹤0.01% |
3,790,381
-3,927,417
| -51% | -$3.55M |
|
|
APLS
2220
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $3.33M | ﹤0.01% |
+108,800
| New | +$3.01M |
|
2221
Endava
DAVA
$170M
| $3.32M | ﹤0.01% |
71,322
-24,016
| -25% | -$1.04M |
|
2222
Upwork
UPWK
$1.13B
| $3.32M | ﹤0.01% |
311,275
+215,675
| +226% | +$2.72M |
|
2223
Cartesian Therapeutics
RNAC
$290M
| $3.32M | ﹤0.01% |
46,443
+37,675
| +430% | +$1.82M |
|
|
ACHN
2224
DELISTED
Achillion Pharmaceuticals
ACHN
| $3.31M | ﹤0.01% |
548,616
-2,739,006
| -83% | -$15.9M |
|
2225
CALL
Analog Devices
ADI
$175B
| $3.3M | ﹤0.01% |
27,800
| – | – |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $4.28B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.